Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 12/20 | 0.57 |
| ▸ | CTSL | P07711 | 3/20 | 0.52 |
| ▸ | CTSS | P25774 | 3/20 | 0.52 |
| ▸ | CTSK | P43235 | 3/20 | 0.52 |
| ▸ | CTSH | P09668 | 1/20 | 0.52 |
| ▸ | MC4R | P32245 | 1/20 | 0.51 |
| ▸ | MC5R | P33032 | 1/20 | 0.51 |
| ▸ | MC3R | P41968 | 1/20 | 0.51 |
| ▸ | MC1R | Q01726 | 1/20 | 0.51 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.51 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.51 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.51 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.49 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30797902 | 0.96 | CXCR4 (0.58) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30797951 | 0.93 | CXCR4 (0.58) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30797905 | 0.89 | MC4R (0.58) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30798008 | 0.89 | MC4R (0.58) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30173921 | 0.89 | MC4R (0.58) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31147129 | 0.89 | CXCR4 (0.58) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30797891 | 0.88 | MC4R (0.55) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL29511552 | 0.88 | CXCR4 (0.57) | CXCR4NTSR2NTSR1SORT1KISS1R | |
| SCHEMBL30797894 | 0.87 | KISS1R (0.56) | CXCR4MC4RMC5RMC3RMC1R | |
| SCHEMBL30797771 | 0.87 | CXCR4 (0.55) | CXCR4NTSR2NTSR1SORT1KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11896704-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2024-02-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11896704-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, MTX1, MTX2 | CXCR4 4011/4885CTSL 3728/4885CTSS 3857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.